| （単位：千ドル） | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | - | - | - | - | - | 2,357 | 2,263 | 2,930 |
| 研究開発費 | 10,470 | 14,920 | 16,246 | 13,038 | 16,131 | 13,218 | 11,051 | 10,400 | 11,216 | 10,759 | 8,266 |
| 営業費用 | 15,961 | 21,224 | 24,552 | 20,206 | 23,526 | 20,116 | 17,361 | 17,487 | 17,061 | 17,025 | 16,781 |
| 営業利益 | -15,961 | -21,224 | -24,552 | -20,206 | -23,526 | -20,116 | -17,361 | -17,487 | -14,704 | -14,762 | -13,851 |
| 営業利益率 (%) | - | - | - | - | - | - | - | - | |||
| 純利益 | -16,251 | -21,353 | -24,613 | -19,790 | -22,646 | -19,355 | -16,748 | -17,200 | -13,925 | -14,020 | -13,265 |
| 純利益率（％） | - | - | - | - | - | - | - | - | |||
| 一株あたり利益 | -21.27 | -0.78 | -0.9 | -0.72 | -0.83 | -0.7 | -0.61 | -0.62 | -0.24 | -0.22 | -0.18 |
| 希薄化後一株あたり利益 | -21.27 | -0.78 | -0.9 | -0.72 | -0.83 | -0.7 | -0.61 | -0.62 | -0.24 | -0.22 | -0.18 |
| EBITDA | - | - | - | - | - | - | - | ||||
| EBITDAマージン（％） | - | - | - | - | - | - | - | - | - | - |